Concepts (103)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Esophageal Neoplasms | 13 | 2024 | 1617 | 2.710 |
Why?
|
Adenocarcinoma | 13 | 2024 | 6298 | 1.670 |
Why?
|
HMGB1 Protein | 1 | 2022 | 139 | 0.750 |
Why?
|
Interleukin-10 | 2 | 2023 | 1156 | 0.740 |
Why?
|
Drug Therapy | 1 | 2020 | 500 | 0.580 |
Why?
|
T-Lymphocytes | 3 | 2022 | 10018 | 0.550 |
Why?
|
Stomach Neoplasms | 3 | 2022 | 1362 | 0.500 |
Why?
|
Immunotherapy | 7 | 2024 | 4594 | 0.380 |
Why?
|
T-Lymphocytes, Regulatory | 2 | 2023 | 3011 | 0.350 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2021 | 5159 | 0.330 |
Why?
|
Tumor Microenvironment | 6 | 2024 | 3694 | 0.310 |
Why?
|
Esophagectomy | 2 | 2022 | 459 | 0.300 |
Why?
|
Drug Synergism | 2 | 2022 | 1731 | 0.290 |
Why?
|
Esophagogastric Junction | 3 | 2022 | 326 | 0.260 |
Why?
|
Gastrointestinal Neoplasms | 2 | 2022 | 950 | 0.230 |
Why?
|
Chemokine CX3CL1 | 1 | 2021 | 57 | 0.190 |
Why?
|
Culture Media, Conditioned | 1 | 2022 | 525 | 0.190 |
Why?
|
Angiogenesis Inducing Agents | 1 | 2022 | 279 | 0.180 |
Why?
|
Glycolysis | 2 | 2020 | 814 | 0.170 |
Why?
|
Thoracic Wall | 1 | 2021 | 199 | 0.170 |
Why?
|
Killer Cells, Natural | 3 | 2024 | 2170 | 0.160 |
Why?
|
Chemotaxis | 1 | 2021 | 595 | 0.160 |
Why?
|
Intra-Abdominal Fat | 1 | 2023 | 580 | 0.150 |
Why?
|
Sarcopenia | 1 | 2022 | 362 | 0.150 |
Why?
|
Appendectomy | 1 | 2020 | 421 | 0.140 |
Why?
|
Interleukin-2 | 1 | 2022 | 1868 | 0.130 |
Why?
|
Antineoplastic Agents | 3 | 2023 | 13538 | 0.120 |
Why?
|
Humans | 24 | 2024 | 746044 | 0.120 |
Why?
|
Pyrazines | 1 | 2020 | 1192 | 0.120 |
Why?
|
Oxygen Consumption | 1 | 2020 | 1824 | 0.110 |
Why?
|
Appendicitis | 1 | 2020 | 663 | 0.110 |
Why?
|
Respiratory Insufficiency | 1 | 2022 | 1210 | 0.110 |
Why?
|
Up-Regulation | 1 | 2022 | 4114 | 0.110 |
Why?
|
Obesity | 3 | 2024 | 12670 | 0.100 |
Why?
|
Combined Modality Therapy | 2 | 2021 | 8511 | 0.100 |
Why?
|
Metabolomics | 1 | 2020 | 1570 | 0.100 |
Why?
|
Inflammation | 3 | 2023 | 10592 | 0.080 |
Why?
|
Hospitals | 1 | 2020 | 3854 | 0.070 |
Why?
|
Neoplasm Staging | 1 | 2021 | 11064 | 0.070 |
Why?
|
Neoadjuvant Therapy | 3 | 2022 | 2787 | 0.070 |
Why?
|
Immunity | 2 | 2022 | 995 | 0.060 |
Why?
|
Multiple Myeloma | 1 | 2023 | 5101 | 0.060 |
Why?
|
Clinical Trials as Topic | 1 | 2020 | 7935 | 0.060 |
Why?
|
Disease Progression | 1 | 2021 | 13303 | 0.060 |
Why?
|
Delivery of Health Care | 1 | 2021 | 5238 | 0.060 |
Why?
|
Colorectal Neoplasms | 1 | 2021 | 6746 | 0.050 |
Why?
|
Ireland | 1 | 2021 | 165 | 0.050 |
Why?
|
Monocarboxylic Acid Transporters | 1 | 2020 | 81 | 0.050 |
Why?
|
Upper Gastrointestinal Tract | 1 | 2021 | 46 | 0.050 |
Why?
|
Signal Transduction | 2 | 2020 | 23112 | 0.050 |
Why?
|
Cell Movement | 2 | 2024 | 5162 | 0.050 |
Why?
|
Hexokinase | 1 | 2020 | 125 | 0.050 |
Why?
|
Glucose Transporter Type 1 | 1 | 2020 | 189 | 0.040 |
Why?
|
L-Lactate Dehydrogenase | 1 | 2020 | 406 | 0.040 |
Why?
|
Carbon Monoxide | 1 | 2022 | 540 | 0.040 |
Why?
|
Nucleotidyltransferases | 1 | 2021 | 235 | 0.040 |
Why?
|
Jurkat Cells | 1 | 2020 | 727 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2022 | 11940 | 0.040 |
Why?
|
Receptors, Chemokine | 1 | 2021 | 651 | 0.040 |
Why?
|
Oxidative Phosphorylation | 1 | 2020 | 488 | 0.040 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2023 | 774 | 0.040 |
Why?
|
Cisplatin | 1 | 2022 | 1637 | 0.030 |
Why?
|
Mitosis | 1 | 2020 | 1190 | 0.030 |
Why?
|
Lactic Acid | 1 | 2020 | 1118 | 0.030 |
Why?
|
Cell Death | 1 | 2021 | 1654 | 0.030 |
Why?
|
Antigens | 1 | 2021 | 1438 | 0.030 |
Why?
|
Ligands | 1 | 2022 | 3266 | 0.030 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2022 | 3476 | 0.030 |
Why?
|
Phenotype | 2 | 2021 | 16245 | 0.030 |
Why?
|
Immune Tolerance | 1 | 2020 | 2215 | 0.020 |
Why?
|
Neoplasms | 1 | 2020 | 21688 | 0.020 |
Why?
|
Immunologic Factors | 1 | 2021 | 1567 | 0.020 |
Why?
|
Endoscopy | 1 | 2021 | 1829 | 0.020 |
Why?
|
Recovery of Function | 1 | 2021 | 2923 | 0.020 |
Why?
|
Chromatin | 1 | 2023 | 2896 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2022 | 3460 | 0.020 |
Why?
|
Female | 7 | 2022 | 382109 | 0.020 |
Why?
|
Cell Survival | 1 | 2020 | 5761 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2021 | 4816 | 0.020 |
Why?
|
Epigenesis, Genetic | 1 | 2023 | 3655 | 0.020 |
Why?
|
Male | 6 | 2022 | 351093 | 0.020 |
Why?
|
Adipose Tissue | 1 | 2021 | 3258 | 0.020 |
Why?
|
Biopsy | 1 | 2020 | 6732 | 0.020 |
Why?
|
Databases, Factual | 1 | 2021 | 7810 | 0.020 |
Why?
|
Prevalence | 1 | 2021 | 15308 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2020 | 10300 | 0.010 |
Why?
|
Health Services Accessibility | 1 | 2021 | 5218 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2021 | 7785 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2020 | 16657 | 0.010 |
Why?
|
Melanoma | 1 | 2021 | 5569 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2021 | 17834 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2022 | 11539 | 0.010 |
Why?
|
Skin Neoplasms | 1 | 2021 | 5688 | 0.010 |
Why?
|
Aged | 2 | 2022 | 164236 | 0.010 |
Why?
|
Cohort Studies | 1 | 2022 | 40503 | 0.010 |
Why?
|
Middle Aged | 2 | 2021 | 214412 | 0.010 |
Why?
|
Adult | 2 | 2021 | 214958 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2021 | 57557 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2021 | 63661 | 0.010 |
Why?
|
Young Adult | 1 | 2020 | 57106 | 0.010 |
Why?
|
Mice | 1 | 2021 | 80087 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2020 | 78297 | 0.010 |
Why?
|
Animals | 1 | 2021 | 166331 | 0.010 |
Why?
|
Concepts
(103)
Derived automatically from this person's publications.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_